108 related articles for article (PubMed ID: 18808364)
21. Retinal Blood Flow Velocity Change in Parafoveal Capillary after Topical Tafluprost Treatment in Eyes with Primary Open-angle Glaucoma.
Iida Y; Akagi T; Nakanishi H; Ohashi Ikeda H; Morooka S; Suda K; Hasegawa T; Yokota S; Yoshikawa M; Uji A; Yoshimura N
Sci Rep; 2017 Jul; 7(1):5019. PubMed ID: 28694501
[TBL] [Abstract][Full Text] [Related]
22. Autoregulation of retinal blood flow in response to decreased ocular perfusion pressure in cats: comparison of the effects of increased intraocular pressure and systemic hypotension.
Tani T; Nagaoka T; Nakabayashi S; Yoshioka T; Yoshida A
Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):360-7. PubMed ID: 24302588
[TBL] [Abstract][Full Text] [Related]
23. Changes in optic nerve head blood flow induced by the combined therapy of latanoprost and beta blockers.
Sugiyama T; Kojima S; Ishida O; Ikeda T
Acta Ophthalmol; 2009 Nov; 87(7):797-800. PubMed ID: 19053956
[TBL] [Abstract][Full Text] [Related]
24. [Combined effect of topical latanoprost and timolol on retinal blood flow and tissue circulation in the optic nerve head in cynomolgus monkeys].
Ishii K; Araie M
Nippon Ganka Gakkai Zasshi; 2000 Jan; 104(1):3-10. PubMed ID: 10659619
[TBL] [Abstract][Full Text] [Related]
25. Effects of topical carteolol on retinal arterial blood flow in primary open-angle glaucoma patients.
Kawai M; Nagaoka T; Takahashi A; Sato E; Yoshida A
Jpn J Ophthalmol; 2012 Sep; 56(5):458-63. PubMed ID: 22695833
[TBL] [Abstract][Full Text] [Related]
26. Role of neuronal nitric oxide synthase in regulating retinal blood flow during flicker-induced hyperemia in cats.
Yoshioka T; Nagaoka T; Song Y; Yokota H; Tani T; Yoshida A
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3113-20. PubMed ID: 25783603
[TBL] [Abstract][Full Text] [Related]
27. Effect of betaxolol on the retinal circulation in eyes with ocular hypertension: a pilot study.
Gupta A; Chen HC; Rassam SM; Kohner EM
Eye (Lond); 1994; 8 ( Pt 6)():668-71. PubMed ID: 7867825
[TBL] [Abstract][Full Text] [Related]
28. Reduction of intraocular pressure in mouse eyes treated with latanoprost.
Aihara M; Lindsey JD; Weinreb RN
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):146-50. PubMed ID: 11773025
[TBL] [Abstract][Full Text] [Related]
29. Effects of pentoxifylline and alprostadil on ocular hemodynamics in healthy humans.
Dorner GT; Zawinka C; Resch H; Wolzt M; Schmetterer L; Garhofer G
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):815-9. PubMed ID: 17251482
[TBL] [Abstract][Full Text] [Related]
30. Retinal arteriolar responses to acute severe elevation in systemic blood pressure in cats: role of endothelium-derived factors.
Nakabayashi S; Nagaoka T; Tani T; Sogawa K; Hein TW; Kuo L; Yoshida A
Exp Eye Res; 2012 Oct; 103():63-70. PubMed ID: 22940370
[TBL] [Abstract][Full Text] [Related]
31. Effect of latanoprost on choroidal blood flow regulation in healthy subjects.
Boltz A; Schmidl D; Weigert G; Lasta M; Pemp B; Resch H; Garhöfer G; Fuchsjäger-Mayrl G; Schmetterer L
Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4410-5. PubMed ID: 21498617
[TBL] [Abstract][Full Text] [Related]
32. Effect of topical carteolol on the normal human retinal circulation.
Grunwald JE; Delehanty J
Invest Ophthalmol Vis Sci; 1992 May; 33(6):1853-6. PubMed ID: 1582788
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug.
Takagi Y; Nakajima T; Shimazaki A; Kageyama M; Matsugi T; Matsumura Y; Gabelt BT; Kaufman PL; Hara H
Exp Eye Res; 2004 Apr; 78(4):767-76. PubMed ID: 15037111
[TBL] [Abstract][Full Text] [Related]
34. Metabolism and ocular tissue distribution of an antiglaucoma prostanoid, tafluprost, after ocular instillation to monkeys.
Fukano Y; Kawazu K; Akaishi T; Bezwada P; Pellinen P
J Ocul Pharmacol Ther; 2011 Jun; 27(3):251-9. PubMed ID: 21491995
[TBL] [Abstract][Full Text] [Related]
35. First-line therapy with latanoprost 0.005% results in improved ocular circulation in newly diagnosed primary open-angle glaucoma patients: a prospective, 6-month, open-label study.
Gherghel D; Hosking SL; Cunliffe IA; Armstrong RA
Eye (Lond); 2008 Mar; 22(3):363-9. PubMed ID: 17115020
[TBL] [Abstract][Full Text] [Related]
36. Effects of topical administration of tafluprost and combination of tafluprost and timolol or tafluprost and betaxolol on Schirmer tear test, intraocular pressure, and pupil size in clinically healthy dogs.
Shokoohimand A; Arfaee F; Asghari A; Khaksar E
Int Ophthalmol; 2020 Oct; 40(10):2585-2592. PubMed ID: 32504308
[TBL] [Abstract][Full Text] [Related]
37. Short-term effects of topical levobunolol on the human retinal circulation.
Leung M; Grunwald JE
Eye (Lond); 1997; 11 ( Pt 3)():371-6. PubMed ID: 9373479
[TBL] [Abstract][Full Text] [Related]
38. Tafluprost, a new potent prostanoid receptor agonist: a dose-response study on pharmacodynamics and tolerability in healthy volunteers.
Sutton A; Gouws P; Ropo A
Int J Clin Pharmacol Ther; 2008 Aug; 46(8):400-6. PubMed ID: 18793581
[TBL] [Abstract][Full Text] [Related]
39. The effect of nipradilol, an alpha-beta blocker, on retinal blood flow in healthy volunteers.
Kida T; Sugiyama T; Harino S; Kitanishi K; Ikeda T
Curr Eye Res; 2001 Aug; 23(2):128-32. PubMed ID: 11840351
[TBL] [Abstract][Full Text] [Related]
40. Topical treatment for 1 week with latanoprost but not diclofenac reduces the diameter of dilated retinal arterioles in patients with type 1 diabetes mellitus and mild retinopathy.
Tilma KK; Bek T
Acta Ophthalmol; 2012 Dec; 90(8):750-5. PubMed ID: 21726428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
